Downregulation of immediate-early genes linking to suppression of neuronal plasticity in rats after 28-day exposure to glycidol

Toxicol Appl Pharmacol. 2014 Sep 1;279(2):150-62. doi: 10.1016/j.taap.2014.05.017. Epub 2014 Jun 8.

Abstract

We previously found that the 28-day oral toxicity study of glycidol at 200mg/kg/day in rats resulted in axonopathy in both the central and peripheral nervous systems and aberrations in the late-stage of hippocampal neurogenesis targeting the process of neurite extension. To capture the neuronal parameters in response to glycidol toxicity, these animals were subjected to region-specific global gene expression profiling in four regions of cerebral and cerebellar architectures, followed by immunohistochemical analysis of selected gene products. Expression changes of genes related to axonogenesis and synaptic transmission were observed in the hippocampal dentate gyrus, cingulate cortex and cerebellar vermis at 200mg/kg showing downregulation in most genes. In the corpus callosum, genes related to growth, survival and functions of glial cells fluctuated their expression. Immunohistochemically, neurons expressing gene products of immediate-early genes, i.e., Arc, Fos and Jun, decreased in their number in the dentate granule cell layer, cingulate cortex and cerebellar vermis. We also applied immunohistochemical analysis in rat offspring after developmental exposure to glycidol through maternal drinking water. The results revealed increases of Arc(+) neurons at 1000ppm and Fos(+) neurons at ≥300ppm in the dentate granule cell layer of offspring only at the adult stage. These results suggest that glycidol suppressed neuronal plasticity in the brain after 28-day exposure to young adult animals, in contrast to the operation of restoration mechanism to increase neuronal plasticity at the adult stage in response to aberrations in neurogenesis after developmental exposure.

Keywords: 28-day oral toxicity study; Glycidol; Immediate-early gene; Microarray; Neurogenesis; Neuronal plasticity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Brain / drug effects*
  • Brain / metabolism
  • Brain / pathology
  • Cytoskeletal Proteins / genetics
  • Cytoskeletal Proteins / metabolism
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Epoxy Compounds / toxicity*
  • Female
  • Gene Expression Profiling / methods
  • Genes, Immediate-Early*
  • Immunohistochemistry
  • Male
  • Maternal Exposure
  • Nerve Tissue Proteins / genetics
  • Nerve Tissue Proteins / metabolism
  • Neurogenesis / drug effects
  • Neurogenesis / genetics
  • Neuronal Plasticity / drug effects*
  • Neuronal Plasticity / genetics
  • Neurons / drug effects*
  • Neurons / metabolism
  • Neurons / pathology
  • Oligonucleotide Array Sequence Analysis
  • Pregnancy
  • Prenatal Exposure Delayed Effects
  • Propanols / toxicity*
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-fos / metabolism
  • Proto-Oncogene Proteins c-jun / genetics
  • Proto-Oncogene Proteins c-jun / metabolism
  • Rats
  • Real-Time Polymerase Chain Reaction
  • Reverse Transcriptase Polymerase Chain Reaction
  • Synaptic Transmission / drug effects
  • Synaptic Transmission / genetics
  • Time Factors

Substances

  • Cytoskeletal Proteins
  • Epoxy Compounds
  • Nerve Tissue Proteins
  • Propanols
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • activity regulated cytoskeletal-associated protein
  • glycidol